Works by Itokawa, Norio


Results: 72
    1

    Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko;
    • Tsutsui, Akemi;
    • Itokawa, Norio
    Publication type:
    Article
    2

    Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    3

    Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    4

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article
    5

    Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
    By:
    • Koroki, Keisuke;
    • Kanogawa, Naoya;
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Maeda, Takahiro;
    • Inoue, Masanori;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Ito, Kenji;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki
    Publication type:
    Article
    6

    Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
    By:
    • Koroki, Keisuke;
    • Kanogawa, Naoya;
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Maeda, Takahiro;
    • Inoue, Masanori;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Ito, Kenji;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki
    Publication type:
    Article
    7

    Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 382, doi. 10.1159/000507022
    By:
    • Maruta, Susumu;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Obu, Masamichi;
    • Inoue, Masanori;
    • Itokawa, Norio;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Okabe, Shinichiro;
    • Azemoto, Ryosaku;
    • Itobayashi, Ei;
    • Atsukawa, Masanori;
    • Sugiura, Nobuyuki;
    • Mizumoto, Hideaki;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    8

    Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.

    Published in:
    Therapeutic Advances in Endocrinology & Metabolism, 2021, p. 1, doi. 10.1177/20420188211000243
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Mikami, Shigeru;
    • Ono, Hiroki;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Tanabe, Tomohide;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Nakagawa-Iwashita, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Emoto, Naoya;
    • Nagao, Mototsugu;
    • Inagaki, Kyoko;
    • Fukuda, Izumi;
    • Sugihara, Hitoshi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    9
    10
    11

    Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    12

    Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Takaguchi, Koichi;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Tajiri, Kazuto;
    • Hirooka, Masashi;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ishikawa, Toru;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Itokawa, Norio;
    • Imai, Michitaka;
    • Joko, Kouji
    Publication type:
    Article
    13

    Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.

    Published in:
    PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224184
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kawano, Tadamichi;
    • Koeda, Mai;
    • Yoshida, Yuji;
    • Tanabe, Tomohide;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Iwashita, Ai;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Kawamoto, Chiaki;
    • Hatori, Tsutomu;
    • Emoto, Naoya;
    • Iio, Etsuko;
    • Tanaka, Yasuhito;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    14

    Correction to: Prophylactic clip closure for mucosal defects is associated with reduced adverse events after colorectal endoscopic submucosal dissection: a propensity-score matching analysis.

    Published in:
    BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02259-0
    By:
    • Omori, Jun;
    • Goto, Osamu;
    • Habu, Tsugumi;
    • Ishikawa, Yumiko;
    • Kirita, Kumiko;
    • Koizumi, Eriko;
    • Noda, Hiroto;
    • Higuchi, Kazutoshi;
    • Onda, Takeshi;
    • Akimoto, Teppei;
    • Akimoto, Naohiko;
    • Itokawa, Norio;
    • Kaise, Mitsuru;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    15

    Prophylactic clip closure for mucosal defects is associated with reduced adverse events after colorectal endoscopic submucosal dissection: a propensity-score matching analysis.

    Published in:
    BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02202-3
    By:
    • Omori, Jun;
    • Goto, Osamu;
    • Habu, Tsugumi;
    • Ishikawa, Yumiko;
    • Kirita, Kumiko;
    • Koizumi, Eriko;
    • Noda, Hiroto;
    • Higuchi, Kazutoshi;
    • Onda, Takeshi;
    • Akimoto, Teppei;
    • Akimoto, Naohiko;
    • Itokawa, Norio;
    • Kaise, Mitsuru;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    16
    17
    18

    Impact of pemafibrate in patients with metabolic dysfunction‐associated steatotic liver disease complicated by dyslipidemia: A single‐arm prospective study.

    Published in:
    JGH Open, 2024, v. 8, n. 4, p. 1, doi. 10.1002/jgh3.13057
    By:
    • Ono, Hiroki;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Arai, Taeang;
    • Suzuki, Kenta;
    • Higashi, Tetsuyuki;
    • Kitamura, Michika;
    • Shioda‐Koyano, Kaori;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Nagao, Mototsugu;
    • Iwabu, Masato;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    19

    How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis.

    Published in:
    JGH Open, 2023, v. 7, n. 8, p. 588, doi. 10.1002/jgh3.12949
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Tamura, Yuichi;
    • Koyano‐Shioda, Kaori;
    • Kawano, Tadamichi;
    • Okubo, Tomomi;
    • Hayama, Korenobu;
    • Arai, Taeang;
    • Itokawa, Norio;
    • Taniguchi, Yu;
    • Tamura, Yudai;
    • Kondo, Chisa;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    20
    21

    Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B.

    Published in:
    JGH Open, 2021, v. 5, n. 1, p. 34, doi. 10.1002/jgh3.12443
    By:
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Hiraoka, Atsushi;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Shimada, Noritomo;
    • Chuma, Makoto;
    • Akito, Nozaki;
    • Uojima, Haruki;
    • Ogawa, Chikara;
    • Asano, Toru;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Senoh, Tomonori;
    • Yamashita, Naoki;
    • Oikawa, Tsunekazu
    Publication type:
    Article
    22

    Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
    By:
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Yoshino, Ryohei;
    • Fujimoto, Kentaro;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    23

    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
    By:
    • Nakagawa, Miyuki;
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kikuchi, Yasuharu;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta
    Publication type:
    Article
    24

    Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02731-5
    By:
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Nakagawa, Miyuki;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kogure, Tadayoshi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke
    Publication type:
    Article
    25
    26

    Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 11, p. 1949, doi. 10.1111/jgh.16302
    By:
    • Futagami, Seiji;
    • Agawa, Shuhei;
    • Nakamura, Ken;
    • Watanabe, Yoshiyuki;
    • Habiro, Mayu;
    • Kawawa, Rie;
    • Yamawaki, Hiroshi;
    • Tsushima, Rina;
    • Kirita, Kumiko;
    • Akimoto, Teppei;
    • Ueki, Nobue;
    • Tomohide, Tanabe;
    • Itokawa, Norio;
    • Suzuki, Nami;
    • Naito, Yutaka;
    • Takeuchi, Keiko;
    • Kashiro, Ayumi;
    • Ohta, Ryu;
    • Mizutani, Satoshi;
    • Taniai, Nobuhiko
    Publication type:
    Article
    27

    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.

    Published in:
    Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 6, p. 1256, doi. 10.1111/jgh.14047
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Shimada, Noritomo;
    • Asano, Toru;
    • Ikegami, Tadashi;
    • Koeda, Mai;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Nakagawa‐Iwashita, Ai;
    • Yoshida, Yuji;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Chuganji, Yoshimichi;
    • Matsuzaki, Yasushi;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    28
    29

    Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 3, p. 443, doi. 10.1111/jgh.12039
    By:
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Hashimoto, Satomi;
    • Fukuda, Takeshi;
    • Matsushita, Yoko;
    • Kidokoro, Hideko;
    • Kobayashi, Tamaki;
    • Narahara, Yoshiyuki;
    • Nakatsuka, Katsuhisa;
    • Kanazawa, Hidenori;
    • Iwakiri, Katsuhiko;
    • Sakamoto, Choitsu
    Publication type:
    Article
    30

    Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 1, p. 51, doi. 10.1111/j.1440-1746.2012.07267.x
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Itokawa, Norio;
    • Narahara, Yoshiyuki;
    • Nakatsuka, Katsuhisa;
    • Hashimoto, Satomi;
    • Fukuda, Takeshi;
    • Matsushita, Yoko;
    • Kidokoro, Hideko;
    • Kobayashi, Tamaki;
    • Kanazawa, Hidenori;
    • Sakamoto, Choitsu
    Publication type:
    Article
    31
    32

    Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.

    Published in:
    Digestive Diseases, 2024, v. 42, n. 6, p. 583, doi. 10.1159/000541660
    By:
    • Iwasaki, Shuichiro;
    • Uojima, Haruki;
    • Sakita, Shinya;
    • Masuda, Sakue;
    • Kubota, Kousuke;
    • Fujikawa, Tomoaki;
    • Okubo, Tomomi;
    • Setsu, Toru;
    • Itokawa, Norio;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Tukiyama, Toshiki;
    • Fujii, Kaoru;
    • Hidaka, Hisashi;
    • Atsukawa, Masanori;
    • Kagawa, Tatehiro;
    • Kako, Makoto;
    • Terai, Shuji;
    • Kusano, Chika
    Publication type:
    Article
    33

    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.

    Published in:
    Digestive Diseases, 2021, v. 39, n. 3, p. 234, doi. 10.1159/000510692
    By:
    • Wada, Naohisa;
    • Uojima, Haruki;
    • Satoh, Takashi;
    • Okina, Sosei;
    • Iwasaki, Shuichiro;
    • Shao, Xue;
    • Takiguchi, Hayato;
    • Arase, Yoshitaka;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Miyazaki, Koji;
    • Hidaka, Hisashi;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Horie, Ryouichi;
    • Suzuki, Takahiro;
    • Koizumi, Wasaburo
    Publication type:
    Article
    34

    Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1266, doi. 10.1111/jvh.13170
    By:
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Atsukawa, Masanori;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Matsumoto, Nobuyuki;
    • Okuse, Chiaki;
    • Tada, Toshifumi;
    • Tsutsui, Akemi;
    • Yamashita, Naoki;
    • Kondo, Chisa;
    • Hayama, Korenobu;
    • Kato, Keizo;
    • Itokawa, Norio;
    • Arai, Taeang;
    • Shimada, Noritomo;
    • Asano, Toru;
    • Uojima, Haruki;
    • Ogawa, Chikara
    Publication type:
    Article
    35

    Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma.

    Published in:
    Cancers, 2020, v. 12, n. 2, p. 293, doi. 10.3390/cancers12020293
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Numata, Kazushi;
    • Hidaka, Hisashi;
    • Toyoda, Hidenori;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirose, Shunji;
    • Atsukawa, Masanori;
    • Itokawa, Norio;
    • Arai, Taeang;
    • Kako, Makoto;
    • Nakazawa, Takahide;
    • Wada, Naohisa;
    • Iwasaki, Shuitirou;
    • Miura, Yuki;
    • Hishiki, Satoshi;
    • Nishigori, Shuhei;
    • Morimoto, Manabu;
    • Hattori, Nobuhiro
    Publication type:
    Article
    36

    Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Itobayashi, Ei;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Nakamura, Kazuyoshi;
    • Moriguchi, Michihisa;
    • Watanabe, Shunji;
    • Ikeda, Masafumi;
    • Kuroda, Hidekatsu;
    • Kawaoka, Tomokazu;
    • Hiraoka, Atsushi;
    • Yasui, Yutaka;
    • Kuzuya, Teiji;
    • Sato, Rui;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kiyono, Soichiro
    Publication type:
    Article
    37

    Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 1, p. 172, doi. 10.1007/s10637-019-00801-8
    By:
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Itokawa, Norio;
    • Inoue, Masanori;
    • Okabe, Shinichiro;
    • Seki, Atsuyoshi;
    • Haga, Yuki;
    • Obu, Masamichi;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Mizumoto, Hideaki;
    • Sugiura, Nobuyuki;
    • Azemoto, Ryosaku;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Yokoyama, Masayuki;
    • Kobayashi, Kazufumi
    Publication type:
    Article
    38
    39

    TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy.

    Published in:
    2019
    By:
    • Iio, Etsuko;
    • Matsuura, Kentaro;
    • Shimada, Noritomo;
    • Atsukawa, Masanori;
    • Itokawa, Norio;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Takaguchi, Koichi;
    • Senoh, Tomonori;
    • Eguchi, Yuichiro;
    • Nomura, Hideyuki;
    • Yoshizawa, Kai;
    • Kang, Jong-Hon;
    • Matsui, Takeshi;
    • Hirashima, Noboru;
    • Kusakabe, Atsunori;
    • Miyaki, Tomokatsu;
    • Fujiwara, Kei;
    • Matsunami, Kayoko;
    • Tsutsumi, Susumu
    Publication type:
    journal article
    40
    41

    Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial.

    Published in:
    Nutrients, 2021, v. 13, n. 6, p. 1874, doi. 10.3390/nu13061874
    By:
    • Okubo, Tomomi;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Ono, Hiroki;
    • Kawano, Tadamichi;
    • Yoshida, Yuji;
    • Arai, Taeang;
    • Hayama, Korenobu;
    • Itokawa, Norio;
    • Kondo, Chisa;
    • Kaneko, Keiko;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    42
    43

    Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.

    Published in:
    Journal of Medical Virology, 2015, v. 87, n. 11, p. 1904, doi. 10.1002/jmv.24244
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Shimada, Noritomo;
    • Abe, Hiroshi;
    • Itokawa, Norio;
    • Nakagawa, Ai;
    • Okubo, Tomomi;
    • Aizawa, Yoshio;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    44
    45

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    46

    Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.

    Published in:
    Hepatology Research, 2024, v. 54, n. 11, p. 993, doi. 10.1111/hepr.14052
    By:
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Ishikawa, Toru;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Watanabe, Tsunamasa;
    • Ogawa, Chikara;
    • Hiraoka, Atsushi;
    • Okubo, Hironao;
    • Uojima, Haruki;
    • Chuma, Makoto;
    • Nozaki, Akito;
    • Kato, Keizo;
    • Mikami, Shigeru;
    • Tani, Joji;
    • Morishita, Asahiro;
    • Tada, Toshifumi;
    • Asano, Toru;
    • Senoh, Tomonori
    Publication type:
    Article
    47

    Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.

    Published in:
    Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Hiraoka, Atsushi;
    • Kobayashi, Satoshi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Hidaka, Hisashi;
    • Iwabuchi, Shogo;
    • Numata, Kazushi;
    • Itobayashi, Ei;
    • Itokawa, Norio;
    • Kariyama, Kazuya;
    • Ohama, Hideko;
    • Hattori, Nobuhiro;
    • Hirose, Shunji;
    • Shibata, Hiroshi;
    • Tani, Joji;
    • Imai, Michitaka;
    • Tajiri, Kazuto;
    • Moriya, Satoshi
    Publication type:
    Article
    48

    Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization.

    Published in:
    Hepatology Research, 2020, v. 50, n. 11, p. 1244, doi. 10.1111/hepr.13560
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Hatano, Masaru;
    • Kondo, Chisa;
    • Shioda, Kaori;
    • Ohno, Hiroki;
    • Kawano, Tadamichi;
    • Hayama, Korenobu;
    • Arai, Taeang;
    • Nakagawa‐Iwashita, Ai;
    • Itokawa, Norio;
    • Kaneko, Keiko;
    • Yoshida, Yuji;
    • Koeda, Mai;
    • Okubo, Tomomi;
    • Yamamoto, Teppei;
    • Yamamoto, Takeshi;
    • Taniai, Nobuhiko;
    • Yoshida, Hiroshi;
    • Kanazawa, Hidenori
    Publication type:
    Article
    49
    50

    Serum soluble sialic acid‐binding immunoglobulin‐like lectin‐7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non‐alcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2020, v. 50, n. 4, p. 466, doi. 10.1111/hepr.13464
    By:
    • Sakamoto, Yuzuru;
    • Yoshio, Sachiyo;
    • Doi, Hiroyoshi;
    • Kawai, Hironari;
    • Shimagaki, Tomonari;
    • Mori, Taizo;
    • Matsuda, Michitaka;
    • Aoki, Yoshihiko;
    • Osawa, Yosuke;
    • Yoshida, Yuji;
    • Arai, Taeang;
    • Itokawa, Norio;
    • Ito, Takanori;
    • Seko, Yuya;
    • Yamaguchi, Kanji;
    • Itoh, Yoshihito;
    • Mise, Yoshihiro;
    • Saiura, Akio;
    • Taketomi, Akinobu;
    • Kanto, Tatsuya
    Publication type:
    Article